Nā ʻōkuhi no ka hoʻohana ʻana i "Lantus Solostar": hoʻohui, analog, kumukūʻai a me nā loiloi mea kūʻai aku

ʻO Lantus kekahi o nā mea hoʻokūkū mua o ka insulin manu. Loaʻa ʻia e ka mea e kāwili ana i ka asparagine acid amino me ka glycine ma ka kūlana 21 o ke kaulahao A a e hoʻohui i ʻelua mau momona o ka arginine amino ma ka kaulahao B i ka waʻa amino acid. ʻO kēia lāʻau lapaʻau e hana ʻia e kahi hui lāʻau lapaʻau Falani nui - Sanofi-Aventis. Ma ke ʻano o nā haʻawina he nui, ua hōʻike ʻia ʻo insulin Lantus ʻaʻole i hōʻemi wale ʻia ka hopena o ka hypoglycemia i hoʻohālikelike ʻia me nā lāʻau lapaʻina o NPH, akā e hoʻomaikaʻi i ka metabolateko. Aia ma lalo kahi ʻōlelo pōkole no ka hoʻohana a me nā loiloi o ka maʻi maʻi.

Hoʻopili pū me nā lāʻau ʻē aʻe

Aia nā lāʻau lapaʻau e pili ana i ka metabolism, ʻo ka hoʻonui ʻana aʻe a i ka hoʻemi ʻana i ka pono o ka insulin.

Hoʻemi i ke kō: agio antidiabetic waha, sulfonamides, ACE inhibitors, salicylates, angioprotectors, monoamine oxidase inhibitors, antiarrhythmic dysopyramides, narcotic analgesics.

E hoʻonui i ke kō: heʻano thyroid, diuretics, sympathomimetics, waha i ka ʻawaʻawa, nā deribia phenothiazine, nā mea hoʻohui o protease.

ʻO kekahi mau mea me ka hopena hypoglycemic a me ka hopena hyperglycemic. E pili ana kēia:

• beta blockers a me ka paʻakai lithium,
• waiʻona
• clonidine (lāʻau antihypertensive).

Nā Hoʻohui

1. ʻAʻole pāpā ʻia ka hoʻohana ʻana i nā maʻi i loaʻa i ka intolerance i ka glargine insulin a i ʻole nā ​​mea kōkua kōkua.
2. Hypoglycemia.
3. Ka hoʻomaʻemaʻe ʻana i ka ketoacidosis maʻi.
4. Na keiki malalo o na makahiki 2.

Loaʻa ʻole paha nā ʻano ʻino e koi, i ʻōlelo nā ʻōlelo aʻoi paha:

• lipoatrophy a i ʻole lipohypertrophy,
• kūwaho kūwaho (Kahe ma Quincke
• ka ʻeha a me ka lohi i ke kino o nā sodium,
• hoʻoulua ʻia a me ka ʻike hoʻokaumaha ʻike.

Ke hoʻololi iā Lantus mai nā insulin ʻē aʻe

Inā hoʻohana ka mea maʻi ma ka insulins medium-duration, a laila ke hoʻololi nei i Lantus, ua loli ka nui o ka nui a me ka hoʻonoho o ka lāʻau. Pono e lawe ʻia ka hoʻololi o ka insulin i ka haukapila.

I ka wā e hiki mai ana, ke nānā aku nei ke kauka i ke kō, ke ola o ka mea maʻi, kaupaona a hoʻoponopono i ka nui o nā waihona e mālama ai. Ma hope o ʻekolu mau mahina, hiki i ka nānā ʻana o ka lāʻau i kuhikuhi ʻia ke nānā ʻia e ka nānā ʻana o ka hemoglobin glycated.

Nā wikiō wikiō:

ʻO ka moʻolelo o kekahi o kā mākou mea heluhelu, ʻo Inga Eremina:

Ke kaumaha nei koʻu koʻikoʻi, kau paona ʻia e like me 3 sumo wrestlers i hui pū ʻia, ʻo ia hoʻi ʻo 92kg.

Pehea e kāohi ai i ka momona nui? Pehea e kū ai i nā loli hormonal a me ka momona. Akā ʻaʻohe mea kūpono ʻole a ʻōpio paha i kahi kanaka e like me kāna kiʻi.

Akā he aha ka mea e hāʻawi ai i ka nalo? Ana i ka lawena? ʻIke au - ma kahi o 5 tausani mau kālā. Nā ʻōnaehana paʻakikī - massage LPG, cavitation, RF hāpai, myostimulation? Ke hoʻolako liʻiliʻi ia - nā kumu papa mai 80 tausani mau rubles me kahi mea aʻoaʻo aʻoaʻo aʻoaʻo. Hiki iā ʻoe ke ʻimi ʻolo e holo ma luna o kahi ʻano kapuahi, a hiki i kahi pupule.

A hea lā hea ka manawa a kēia manawa? ʻAe a kūʻai lilo loa. I kēia manawa. No laila, iaʻu iho, ua koho wau i kahi ala ʻē aʻe.

I Lūkini, ua neʻe paʻa ʻia nā maʻi diabetes i hilinaʻi ʻia mai Lantus a i Tujeo. Wahi a nā haʻawina, ʻo ka lāʻau hou ke hoʻohaʻahaʻa loa i ka ulu ʻana o ka hypoglycemia, akā ma ka hoʻomaʻamaʻa ka hapanui o ka poʻe e ʻōhumu ana ma hope o ka hoʻololi ʻana iā Tujeo e lele ikaika ana kā lākou mau kōmaʻa, no laila ua koi ʻia lākou e kūʻai i ka Lantus Solostar insulin ma luna o lākou iho.

He lāʻau maikaʻi loa ʻo Levemir, akā aia kahi ʻano ikaika ʻē aʻe, ʻoiai ʻo ka lōʻihi o ka hana he 24 mau hola.

ʻAʻole i hālāwai ʻo Aylar i ka insulin, ke ʻōlelo mai nā ʻōlelo e like me kēia ka Lantus, akā ʻoi aku ka maʻalahi o ka mea hana.

Insulin Lantus i ka wā hāpai

ʻAʻole i hoʻokō ʻia nā hoʻopaʻa haʻawina maʻamau ʻo Lantus me nā wahine hāpai. Wahi a nā kumuwaiwai ʻole, ʻaʻole maikaʻi ka hopena o ka lāʻau lapaʻau i ka papa o ka hāpai ʻana a ʻo ke keiki ponoʻī nō ia.

Ua hōʻike ʻia nā hoʻokolohua ma luna o nā holoholona, ​​i ka manawa i hōʻike ʻia ai ka hopena o ka glargine i mea ʻole i ka hopena o ka reproduction.

Hiki i ke ʻōpiopio ʻo Lantus Solostar ke kuhikuhi i ka hihia o ka insulin NPH hiki ʻole. Pono ka mālama ʻana o nā makuahine i kā lākou mau momi, no ka mea, ʻo ka hoʻomaʻama mua ʻana, hiki i ka insulin ke hōʻemi, a ma ka lua o ke kolamu ʻoi.

Mai makaʻu i ka hānai hānai i kahi pēpē; ʻaʻole i ʻike nā ʻōlelo i hiki iā Lantus ke hoʻokomo i ka waiū umauma.

ʻO 3 mau makahiki ka noho pale ola o Lantus. Pono ʻoe e mālama i kahi pouli a pale i ka mālama mai ka lā ma kahi mahana o 2 a 8 degere. ʻO ka maʻamau ka nui o ka wahi kūpono ka pahu hau. I kēia hihia, e makaʻala ʻoe e nānā i ke kaomi piha, no ka mea ʻae ʻia ka manuahi o ka Lantus insulin!

Mai ka hoʻohana mua ʻana, hiki ke mālama ʻia ka lāʻau lapaʻau no hoʻokahi mahina i kahi wahi pouli i kahi mahana ʻaʻole iʻoi aku ma mua o 25 tikelika (ʻaʻole i loko o ka friji). Mai hoʻohana i ka insulin pau pau.

Kahi e kūʻai aku ai, kūʻai

Noi ʻia ʻo Lantus Solostar i ʻole e ʻae ʻia e ka lāʻau lapaʻau e ka endocrinologist. Akā e kū kekahi i ka mea maʻi hānai i ke kūʻai aku i kēia lāʻau lapaʻau ponoʻī ma kāna mau keiki i ka hale kūʻai. ʻO ka awelika kumukūʻai o insulin e 3300 rubles. I Ukraine, hiki ke kūʻai aku iā Lantus no 1200 UAH.

Wahi a ka maʻi maʻi, he mea maikaʻi loa ka insulin, e mālama ʻia ko lākou honu i loko o nā palena maʻamau. Eia ka mea a ka poʻe e ʻōlelo ai no Lantus.

ʻO ka hapa nui o nā loiloi maikaʻi wale nō. Wahi a kekahi poʻe ʻo Levemir a ʻo Tresiba ʻoi aku ka maikaʻi no lākou.

Lantus Solostar

Lantus solostar 100ed / ml 3ml 5 pcs. hoʻonā no ka ʻākala subcutaneous o ka pahu pahu. i sp.-hopu.

Sanofi (Lūkini) hoʻomākaukau: Lantus solostar

Nā kikowaena mai ka Insulin māhele

Actrapid nm 100 u / ml 10 ml inao

ʻO Novo Nordisk A / C (Kaʻena) Hoʻomākaukau: Actrapid nm

Humalog 100me / ml 3ml 5 pcs. hoʻonā no ka hoʻolālā o intravenous a me ka subcutaneous o kahi pahu lāʻau

Eli Lilly East S.A. (Farani) Hoʻomau: Humalog

Biosulin n 100me / ml 3ml 5 pcs. ka hoʻokuʻu ana no ka hoʻokele subutaneus i nā pahu pahu. i sp.-hopu.

Lapaʻau Kūʻai Lūkini (Lūkini): Biosulin n

Levemir flekspen 100ed / ml 3ml 5 pcs. rr-r no ka hooponopono o subcutaneous o na cartridges. i sp.-hopu.

ʻO Novo Nordisk A / C (ʻIkena) hoʻomākaukau: Levemir flekspen

Kūpono mai ka Mahele maʻi ʻoihana

5 mg maninil 120 pcs. ʻO nā pōpō

ʻO Berlin Chemie (Kelemānia) hoʻomākaukau: Maninil

Gliformin 1000mg 60 mau pcs. pani ʻ -lelo ʻlelo

Hoʻomākaukau Akrikhin (Lūkini): Gliformin

Glurenorm 30mg 60 mau pcs. ʻO nā pōpō

Beringer Ingelheim Pharma (Kelemānia) Hoʻomākaukau: Glurenorm

Siofor 500mg 60 mau pcs. nā papa i kuʻi

ʻO Berlin Chemie (Kelemānia) Hoʻomākaukau: Siofor 500

Siofor 850mg 60 mau pcs. nā papa i kuʻi

ʻO Berlin Chemie (Kelemānia) Hoʻomākaukau: Siofor 850

E hoʻokuʻu i ke ʻano, ka hoʻonohonoho ʻana a me ka pōpoki

ʻO ke kūleʻa no ka hoʻokele sc ke aniani, ʻokoʻa ʻole a ʻulaʻula ʻole.

ʻO nā mea waiwai: metacresol (m-cresol) - 2.7 mg, zinc klorida - 0,0626 mg (e like me 30 μg zinc), glycerol (85%) - 20 mg, sodium hydroxide - a hiki i ka pH 4.0, ka waikawa hydrochloric - a hiki i ka pH 4.0, ka wai d / a - hiki i ka 1 ml.

3 ml - nā pahu leo ​​mai ke aniani, ʻaʻole aniani nā kākā (type I), i kau ʻia ma SoloStar disable syringe penens (5) - nā pā kāleka me kahi mea hoʻopaʻa pahu pahu.

Ka hana lāʻau lapaʻau

KĀNAKA O NAHUI KA WAHINE!

ʻO ka hana ikaika a Lantus ka insulin glargine. Loaʻa ʻia e ka genetic recombination ma ke ʻano he k-12 kaha o ke bacterium Escherichia coli. I kahi wahi kūʻokoʻa, hoʻokaʻawale iki ia, i loko o kahi mehe e hoʻokahe ana me ka hoʻokumu ʻana o ka microprecipitate, e kū mau ana a hoʻokuʻu iki i ka insulin. Ma muli o kēia, ua kūpono ʻo Lantus i kahi kaila hana maikaʻi a paʻa i nā hola 24.

ʻO ka moʻolelo o kekahi o kā mākou mea heluhelu Alina R .:

Ma ke kālā ua lilo ia i mea nui kuʻu manaʻo. No ka mea, loaʻa iaʻu kahi pūʻulu o nā mea paʻakikī. Ua manaʻo wau iaʻu iho kahi maikaʻi ʻole, nā pilikia ma ka hana a ma koʻu ola ponoʻī. Eia naʻe, ua hoʻoholo wau e pono mau i ke kōkua pilikino. I kekahi manawa aia nō iā ʻoe nā mea pili iā ʻoe iho, ʻo nā hemahema a pau wale nō ia o ka hopena o ka ikaika maikaʻi ʻole, a he maka hewa, a i ʻole kekahi ʻano mana ʻino.

He mea paʻakikī ke leʻaleʻa e hana nei i ka mea mālama kālā no 26t.r. i ka wā e uku ai ʻoe he 11 tausani no ka hale hoʻolimalima. He aha kaʻu mea i hoʻomaka ai i ka loli koke ʻana o koʻu ola holoʻokoʻa i ka pō no ka ʻoi aku ka maikaʻi. ʻAʻole hiki iaʻu ke noʻonoʻo i ka hiki ke loaʻa iā ʻoe ka nui o ka kālā i hiki i kekahi trinket ke nānā mua i kēlā hopena. Ua hoʻomaka ka mea āpau me kaʻu i kauoha ai i kahi pilikino.

ʻO nā waiwai nui a ka pharmacological:

• Hoʻololi i ka adsorption a me ka profile pae ʻole ma waena o 24 mau hola.
• ʻO ka hoʻomakeʻa ʻana o ka proteolysis a me ka lipolysis i nā adipocytes.
• Hoʻohālikelike ka mea hana i nā ʻenehana receptor 5-8 mau manawa ikaika.
• Ka hoʻoponopono o ka hoʻohuihui glucose, pale i ka hoʻomohala i ka glucose i loko o ka puʻuwai.

I loko o 1 ml Lantus Solostar e loaʻa:

• 3.6378 mg o ka insulin glargine (ma nā ʻōlelo o 100 IU o ka insulin kanaka),
• ʻO 85% ka glycerol
• wai no ka uliaa
• h? acid ka wai hamia
• m-cresol a me ka sodium hydroxide.

Lantus - kahi hōʻike kūmole no ka inikini sc, loaʻa i ke ʻano o:

• Nā pahu kaʻa no ka ʻōnaehana OptiKlik (5pcs i kēlā me kēia pā)
• 5 ʻringlelo penikala ʻo Lantus Solostar,
• ʻO peniSet syringe pen i hoʻokahi pahu 5 pcs. (anuʻi 2 papa),
• 10 ml kīwī (1000 hui i loko o hoʻokahi pahu).

Nā hōʻailona no ka hoʻohana ʻana

1. ʻO nā pākeke a me nā keiki mai nā makahiki 2 me ke ʻano maʻi type 1.
2. Kūmole 2 diabetes mellitus (ma ke ʻano o ka maikaʻi ʻole o nā papa).

I loko o ka momona, he kūpono ka hoʻomaʻemaʻe hui - Lantus Solostar a me Metformin.

Hoʻopili pū me nā lāʻau ʻē aʻe

Aia nā lāʻau lapaʻau e pili ana i ka metabolism, ʻo ka hoʻonui ʻana aʻe a i ka hoʻemi ʻana i ka pono o ka insulin.

Hoʻemi i ke kō: agio antidiabetic waha, sulfonamides, ACE inhibitors, salicylates, angioprotectors, monoamine oxidase inhibitors, antiarrhythmic dysopyramides, narcotic analgesics.

E hoʻonui i ke kō: heʻano thyroid, diuretics, sympathomimetics, waha i ka ʻawaʻawa, nā deribia phenothiazine, nā mea hoʻohui o protease.

ʻO kekahi mau mea me ka hopena hypoglycemic a me ka hopena hyperglycemic. E pili ana kēia:

• beta blockers a me ka paʻakai lithium,
• waiʻona
• clonidine (lāʻau antihypertensive).

Nā Hoʻohui

1. ʻAʻole pāpā ʻia ka hoʻohana ʻana i nā maʻi i loaʻa i ka intolerance i ka glargine insulin a i ʻole nā ​​mea kōkua kōkua.
2. Hypoglycemia.
3. Ka hoʻomaʻemaʻe ʻana i ka ketoacidosis maʻi.
4. Na keiki malalo o na makahiki 2.

Loaʻa ʻole paha nā ʻano ʻino e koi, i ʻōlelo nā ʻōlelo aʻoi paha:

• lipoatrophy a i ʻole lipohypertrophy,
• kūwaho kūwaho (Kahe ma Quincke
• ka ʻeha a me ka lohi i ke kino o nā sodium,
• hoʻoulua ʻia a me ka ʻike hoʻokaumaha ʻike.

Ke hoʻololi iā Lantus mai nā insulin ʻē aʻe

Inā hoʻohana ka mea maʻi ma ka insulins medium-duration, a laila ke hoʻololi nei i Lantus, ua loli ka nui o ka nui a me ka hoʻonoho o ka lāʻau. Pono e lawe ʻia ka hoʻololi o ka insulin i ka haukapila.

I ka wā e hiki mai ana, ke nānā aku nei ke kauka i ke kō, ke ola o ka mea maʻi, kaupaona a hoʻoponopono i ka nui o nā waihona e mālama ai. Ma hope o ʻekolu mau mahina, hiki i ka nānā ʻana o ka lāʻau i kuhikuhi ʻia ke nānā ʻia e ka nānā ʻana o ka hemoglobin glycated.

Nā wikiō wikiō:

ʻO ka moʻolelo o kekahi o kā mākou mea heluhelu, ʻo Inga Eremina:

Ke kaumaha nei koʻu koʻikoʻi, kau paona ʻia e like me 3 sumo wrestlers i hui pū ʻia, ʻo ia hoʻi ʻo 92kg.

Pehea e kāohi ai i ka momona nui? Pehea e kū ai i nā loli hormonal a me ka momona. Akā ʻaʻohe mea kūpono ʻole a ʻōpio paha i kahi kanaka e like me kāna kiʻi.

Akā he aha ka mea e hāʻawi ai i ka nalo? Ana i ka lawena? ʻIke au - ma kahi o 5 tausani mau kālā. Nā ʻōnaehana paʻakikī - massage LPG, cavitation, RF hāpai, myostimulation? Ke hoʻolako liʻiliʻi ia - nā kumu papa mai 80 tausani mau rubles me kahi mea aʻoaʻo aʻoaʻo aʻoaʻo. Hiki iā ʻoe ke ʻimi ʻolo e holo ma luna o kahi ʻano kapuahi, a hiki i kahi pupule.

A hea lā hea ka manawa a kēia manawa? ʻAe a kūʻai lilo loa. I kēia manawa. No laila, iaʻu iho, ua koho wau i kahi ala ʻē aʻe.

I Lūkini, ua neʻe paʻa ʻia nā maʻi diabetes i hilinaʻi ʻia mai Lantus a i Tujeo. Wahi a nā haʻawina, ʻoi aku ka hopena o ka lāʻau hou i ka hoʻomohala ʻana i ka hypoglycemia, akā ma ka hoʻomaʻamaʻa ka hapanui o ka poʻe e ʻōlelo ana ma hope o ka hoʻololi ʻana iā Tujeo e lele ikaika ana kā lākou puna, no laila ua koi ʻia lākou e kūʻai i ka Lantus Solostar insulin ma luna o kā lākou.

He lāʻau maikaʻi loa ʻo Levemir, akā aia kahi ʻano ikaika ʻē aʻe, ʻoiai ʻo ka lōʻihi o ka hana he 24 mau hola.

ʻAʻole i hālāwai ʻo Aylar i ka insulin, ke ʻōlelo mai nā ʻōlelo e like me kēia ka Lantus, akā ʻoi aku ka maʻalahi o ka mea hana.

Insulin Lantus i ka wā hāpai

ʻAʻole i hoʻokō ʻia nā hoʻopaʻa haʻawina maʻamau ʻo Lantus me nā wahine hāpai. Wahi a nā kumuwaiwai ʻole, ʻaʻole maikaʻi ka hopena o ka lāʻau lapaʻau i ka papa o ka hāpai ʻana a ʻo ke keiki ponoʻī nō ia.

Ua hōʻike ʻia nā hoʻokolohua ma luna o nā holoholona, ​​i ka manawa i hōʻike ʻia ai ka hopena o ka glargine i mea ʻole i ka hopena o ka reproduction.

Hiki i ke ʻōpiopio ʻo Lantus Solostar ke kuhikuhi i ka hihia o ka insulin NPH hiki ʻole. Pono ka mālama ʻana o nā makuahine i kā lākou mau gula, no ka mea, ʻo ka hoʻomaʻama mua ʻana, hiki i ka insulin ke emi, a i ka lua o ke kolamu ʻoi.

Mai makaʻu i ka hānai hānai i kahi pēpē; ʻaʻole i ʻike nā ʻōlelo i hiki iā Lantus ke hoʻokomo i ka waiū umauma.

ʻO 3 mau makahiki ka noho pale ola o Lantus. Pono ʻoe e mālama i kahi pouli a pale i ka mālama mai ka lā ma kahi mahana o 2 a 8 degere. ʻO ka maʻamau ka nui o ka wahi kūpono ka pahu hau. I kēia hihia, e makaʻala ʻoe e nānā i ke kāohi wela, no ka mea ʻae ʻia ka manuahi o ka Lantus insulin!

Mai ka hoʻohana mua ʻana, hiki ke mālama ʻia ka lāʻau lapaʻau no hoʻokahi mahina i kahi wahi pouli i kahi mahana ʻaʻole iʻoi aku ma mua o 25 tikelika (ʻaʻole i loko o ka friji). Mai hoʻohana i ka insulin pau pau.

Kahi e kūʻai aku ai, kūʻai

Noi ʻia ʻo Lantus Solostar i ʻole e ʻae ʻia e ka lāʻau lapaʻau e ka endocrinologist. Akā e kū kekahi i ka mea maʻi hānai i ke kūʻai aku i kēia lāʻau lapaʻau ponoʻī ma kāna mau keiki i ka hale kūʻai. ʻO ka awelika kumukūʻai o insulin e 3300 rubles. I Ukraine, hiki ke kūʻai aku iā Lantus no 1200 UAH.

Wahi a ka maʻi maʻi, he mea maikaʻi loa ka insulin, e mālama ʻia ko lākou honu i loko o nā palena maʻamau. Eia ka mea a ka poʻe e ʻōlelo ai no Lantus.

ʻO ka hapa nui o nā loiloi maikaʻi wale nō. Wahi a kekahi poʻe ʻo Levemir a ʻo Tresiba ʻoi aku ka maikaʻi no lākou.

Lantus Solostar

Lantus solostar 100ed / ml 3ml 5 pcs. hoʻonā no ka ʻākala subcutaneous o ka pahu pahu. i sp.-hopu.

Sanofi (Lūkini) hoʻomākaukau: Lantus solostar

Nā kikowaena mai ka Insulin māhele

Actrapid nm 100 u / ml 10 ml inao

ʻO Novo Nordisk A / C (Kaʻena) Hoʻomākaukau: Actrapid nm

Humalog 100me / ml 3ml 5 pcs. hoʻonā no ka hoʻolālā o intravenous a me ka subcutaneous o kahi pahu lāʻau

Eli Lilly East S.A. (Farani) Hoʻomau: Humalog

Biosulin n 100me / ml 3ml 5 pcs. ka hoʻokuʻu ana no ka hoʻokele subutaneus i nā pahu pahu. i sp.-hopu.

Lapaʻau Kūʻai Lūkini (Lūkini): Biosulin n

Levemir flekspen 100ed / ml 3ml 5 pcs. rr-r no ka hooponopono o subcutaneous o na cartridges. i sp.-hopu.

ʻO Novo Nordisk A / C (ʻIkena) hoʻomākaukau: Levemir flekspen

Kūpono mai ka Mahele maʻi ʻoihana

5 mg maninil 120 pcs. ʻO nā pōpō

ʻO Berlin Chemie (Kelemānia) hoʻomākaukau: Maninil

Gliformin 1000mg 60 mau pcs. pani ʻ -lelo ʻlelo

Hoʻomākaukau Akrikhin (Lūkini): Gliformin

Glurenorm 30mg 60 mau pcs. ʻO nā pōpō

Beringer Ingelheim Pharma (Kelemānia) Hoʻomākaukau: Glurenorm

Siofor 500mg 60 mau pcs. nā papa i kuʻi

ʻO Berlin Chemie (Kelemānia) Hoʻomākaukau: Siofor 500

Siofor 850mg 60 mau pcs. nā papa i kuʻi

ʻO Berlin Chemie (Kelemānia) Hoʻomākaukau: Siofor 850

LANTUS SoloStar

Nā ʻoihana ʻoihana ʻo ka lāʻau maʻi

ʻO ke ʻano waiwai

E hoʻokuʻu i ke ʻano, ka hoʻonohonoho ʻana a me ka pōpoki

ʻO ke kūleʻa no ka hoʻokele sc ke aniani, ʻokoʻa ʻole a ʻulaʻula ʻole.

ʻO nā mea waiwai: metacresol (m-cresol) - 2.7 mg, zinc klorida - 0,0626 mg (e like me 30 μg zinc), glycerol (85%) - 20 mg, sodium hydroxide - a hiki i ka pH 4.0, ka waikawa hydrochloric - a hiki i ka pH 4.0, ka wai d / a - hiki i ka 1 ml.

3 ml - nā pahu leo ​​mai ke aniani, ʻaʻole aniani nā kākā (type I), i kau ʻia ma SoloStar disable syringe penens (5) - nā pā kāleka me kahi mea hoʻopaʻa pahu pahu.

Ka hana lāʻau lapaʻau

ʻO ka glargine Insulin he mea hoʻopili o ka insulin o ke kanaka i loaʻa e ka hakakā ʻana o nā huina DNA o nā ʻano Escherichia coli (kūlia K12) a hōʻailona ʻia e ka haʻahaʻa haʻahaʻa i kahi pōʻaiwi kūʻai.

ʻO ka mahele o ka lāʻau lapaʻau Lantus SoloStar, kūlohelohe piha ka insulin glargine, ka mea i hōʻoia ʻia e ka hopena o ka waikela o ka hopena no ka ʻawaʻī (pH 4). Ma hope o ka hoʻopuka ʻana i ka momona subcutaneous, ke kūlohelohe ka hopena o ka hopena o ka hoʻonā, e alakaʻi ana i ka hoʻokumu ʻana o ka microprecipitate, mai nā mea liʻiliʻi o ka lolo o ka insulin e hoʻokuʻu mau nei, e hāʻawi ana i ka pālahalaha (me nā peaks) o ka pihi o ka paʻa-manawa, a me ka hana lōʻihi o ka lāʻau.

ʻO ka glulinine Insulin ka mea e hoʻolālā ai i nā metabolites ikaika ʻelua, M1 a me M2.

ʻO ka kamaʻilio me nā mea ʻona insulin: nā kinetics o ka hoʻopili ʻana i ka mea i loaʻa i ka insulin recepty i ka glargine insulin a me nā metabolites M1 a me M2 like like me ia i ka insulin kanaka, a no laila hiki i ka glargine insulin ke hana i kahi hopena koi like e like me ia i ka insulin endogenous.

ʻO ka hana koʻikoʻi o ka insulin a me kāna mau analogues, ʻo ia hoʻi a me ka glargine insulin, ʻo ia ka hoʻoponopono o nā kaila hana o ka glucose. ʻO ka insulin a me kona mau mele nā ​​hōʻemi i ka hoʻoliʻi o ka glucose i loko o ke koko, e hoʻoulu ai i ka lilo ʻana o ka glucose i nā kopa peripheral (ʻoi aku ka kikoʻī o ke kikoʻī a me ke kiko adipose) a me ka pale ʻana i ka hoʻokumu ʻana o ka glucose i loko o ka ate. Hoʻopili ke Insulin i ka lipolysis ma adipocytes a pale i ka proteolysis, ʻoiai e hoʻonui ana i ka synt synthesis.

ʻO ka lōʻihi o ka hana o ka glargine insulin e pili pono ana i ka hoʻemi iki o kona kōpili, e ʻae ai i ka lāʻau lapaʻau e hoʻohana 1 manawa / lā. Ma hope o ka hoʻomalu sc, ka hoʻomaka ʻana o kāna hana, ma ka awelika, ma hope o ka hola 1. ʻO ka lōʻihi o ka hana o 24 mau hola, ʻoi loa ka nui o 29 mau hola.ʻO ka lōʻihi o ka hana o ka insulin a me nā kūlike ona, e like me ka insulin glargine, hiki i nā mea like ʻole i nā mea maʻi like ʻole a i hoʻokahi. ʻo ka mea maʻi.

Ua hōʻike ʻia ka maikaʻi o ka lāʻau Lantus SoloStar i nā keiki i ʻoi aku o nā makahiki he 2 mau makahiki me nā maʻi maʻi type 1. I nā keiki i ka makahiki o 2-6 mau makahiki, ʻo ka ulu ʻana o ka hypoglycemia me nā hōʻailona noʻonoʻo i ka wā e hoʻohana ai i ka glargine insulin i lalo o ka lā a me ka pō e hoʻohālikelike ʻia me ka hoʻohana ʻana o ka insulin-isofan (ma kēlā me kēia, ma ka pae 25.5 mau episekole ma 33 episode i loko. hoʻokahi kanaka maʻi no hoʻokahi makahiki).

I ka mālama ʻia ʻana o nā mea maʻi ʻelima mau makahiki me ka mellitus type type 2, ʻaʻohe ʻano nui o ka hoʻomohala ʻana o ka retinopathy maʻi diabetes me nā glargine insulin i hoʻohālikelike ʻia me insulin-isophan.

ʻO ka pilina me nā mea nānā i ka like me ka like o ka insulin e like me 1 (IGF-1): ka pilina o ka glargine insulin no ka mea hoʻokipa IGF-1 ma kahi o 5-8 mau manawa ma mua o ka insulin o ke kanaka (akā ma kahi o 70-80 mau manawa haʻahaʻa ma mua o ka IGF-1). i ka manawa like, i ka hoʻohālikelike ʻana me ka insulin kanaka, ʻoi ka liʻiliʻi o ka metabolism o ka insulin glargine M1 a me ka M2 o ka mea hoʻokipa ma ka IGF-1.

ʻO ka nui o ka therapeutic concentrations o ka insulin (insulin glargine a me nā metabolites), i hoʻoholo ʻia i loko o nā mea maʻi me ka type 1 diabetes mellitus, i hoʻohaʻahaʻa loa ʻia ma mua o ke kao e koi ai no ka hapalua nui o nā hāmeʻa i ka IGF-1 a me ka hoʻihoʻi ma hope o ke ala e pili ana i ka proliferative e pili ana i ka IGF-1. Hiki i nā mea paʻa o ka phogenological o ka endogenous IGF-1 ke hiki i ka huakaʻi holomua proliferative ke ala, akā, ka hopena o ka insulin therapeutic i hoʻoholo ʻia i ka wā o ka hoʻoulu ʻana i ka insulin, me ka mālama ʻana me Lantus SoloStar, i hoʻohaʻahaʻa loa ʻia ma mua o nā ʻoihana pharmacological i koi ʻia e hoʻōla i ka huakaʻi proliferative.

ʻO ke aʻo ORIGIN (Outcome Reduction with Initial Glargine INtervention) he pānaʻi, lehulehu, multicenter, randomized study hana i loko o 12,537 mau mea maʻi me ka hopena kiʻekiʻe o ka hoʻomohala ʻana i ka maʻi cardiovascular a me kahi keʻakeʻa wikiwiki ʻaole (NGN), ka hoʻohaʻahaʻa glucose aniani (NTG) a i ʻole ka wā mua diabetes type 2. Ua hana maʻalahi ʻia nā mea noiʻi i loko o nā hui (1: 1): he hui o nā mea maʻi e loaʻa ana i ka glargine insulin (n = 6264), kahi i hoʻohālikelike ʻia ma mua o ka hōʻea ʻana o ka kukuna glucose koko ʻole (GKN) ≤5.3 mmol, a me kahi hui o nā maʻi e loaʻa ana i ka lapaʻau maʻamau (n = 6273 )

ʻO ka mea mua o ka hoʻopaʻa ʻana ʻo ia ka manawa ma mua o ka hoʻomohala ʻana o ka make cardiovascular, ka hoʻomaka mua ʻana o ka maʻi nonocardial non-fatal a i ʻole nā ​​mea hōʻeha nonā, a ʻo ka hopena lua ka manawa ma mua o ka hoʻopiʻi mua ʻana o kekahi o nā mea i luna a i mua paha o ke kaʻina o ka revascularization (coronary, carotid a peripheral arteries) , a ma mua o ka hana hoʻokipa ma ka hoʻomohala ʻana o ka hana naʻau ʻole.

ʻO nā make liʻiliʻi he make no ke kumu a me ke kaʻina hui o nā hopena microvascular.

Ua hōʻike ʻia ka haʻawina ʻo ORIGIN e like me ka mālama ʻana o ka maʻi glargine i hoʻohālikelike ʻia e ka maʻi hypoglycemic standard i hoʻololi ʻole i ka hōʻeha o nā hoʻopiʻi cardiovascular a i ʻole ka make ʻana o ka maʻi cardiovascular, ʻaʻohe ʻano ʻē aʻe o nā pae i hoʻohālikelike i nā kihi hope, make ʻana mai nā kumu āpau, hui pū me nā huaʻala o nā hopena microvascular. . ^ E Ha yM.

I ka hoʻomaka o ka hoʻopaʻa noi ʻana, ʻo ka helu median ʻo Hb A1c ʻo 6.4%. ʻO ka helu median Hb A1c i ka wā o ka mālamaʻana aia i ka palena o 5.9-6.4% i ka hui glargine insulin a me 6.2-6.6% i ka hui mālama maʻi maʻamau a puni ka manawa nānā.

I ka hui o nā mea maʻi e loaʻa ana i ka glargine insulin, ʻo ka mea i loaʻa i ka hypoglycemia koʻikoʻi he mau kikowaena 1.05 ma kēlā me kēia 100 mau makahiki maʻi maʻi, a ma ka hui o nā mea maʻi i loaʻa i ke ʻano o ka maʻi hypoglycemic maʻamau 0.3 mau episetole i 100 mau makahiki maʻi o ka maʻi o ka pena. ʻO ka ulu ʻana o ka hypoglycemia mālie he 7.71 manawa ma kēlā me kēia 100 mau makahiki maʻi o ka hōʻeha i ka hui o nā mea maʻi e loaʻa ana i ka gologine insulin, a me nā 2.44 episodelika ma kahi o 100 mau makahiki maʻi o ka hoʻomohala ma ka pūʻulu o nā maʻi e loaʻa ana i ka hypoglycemia maʻamau. Ma kahi haʻawina 6 makahiki, ʻo 42% o nā mea maʻi i ka hui glargine insulin i hōʻike ʻole i nā hihia o ka hypoglycemia.

ʻO ka median o nā loli i ke kaumaha o ke kino e hoʻohālikelike ʻia me ka hopena i ka kipa hoʻomaʻamaʻa hope loa he 2.2 kg ʻoi aku ke kiʻekiʻe o ka hui glargine insulin ma mua o ka hui mālama maʻi.

Pākuʻi helu

Inikua 100 U / ml

1 ml o ka hoʻonā i loaʻa:

nā mea ikaika: insulin glargine NOE 901 - 3.6378 mg (100 PIECES).

nā mea waiwai: metacresol, zinc chloride, glycerin (85%), sodium hydroxide, concentrated hydrochloric acid, ka wai no ka injection.

ʻAʻohe liuliu a ʻokoʻa ʻole nā ​​ʻāpana like ʻole.

ʻO nā waiwai Pharmacological

Hoʻohālikelike ʻia i ka NPH-insulin kanaka, kūloko o ka serum insulin i nā kumuhana olakino a me nā poʻe maʻi me ka maʻi diabetes ma hope o ka mālama ʻana a subcutaneous o ka insulin glargine i hōʻike i ka wikiwiki a me ka lōʻihi o ka lilo ʻana, a me ka hoʻoneʻe ʻana o nā peaks. Pēlā, e like me nā kūmole o ke kino o ka hana pharmacodynamic o ka glargine insulin. Hōʻike ke kiʻina 1 i nā hana hana no ka insulin glargine a me NPH-insulin ma mua o ka manawa. Me ka hoʻopuka ʻana i hoʻokahi manawa i hoʻokahi lā, ua loaʻa ka kūlike kōpae o ka glucose o ka insulin glargine i loko o ke koko a hiki i ka lā 2 mau lā ma hope o ke ʻano o ka hopena mua. Me ka hoʻokele intravenous, ua hoʻohālikelike ka hapalua o nā ola o ka insulin glargine a me nā insulin kanaka.

Ma hope o ka hoʻonāʻana o ka subcutaneous o Lantus i nā poʻe maʻi me ka maʻi mellitus, ua hoʻāo nui ka insulin glargine i ka hopena o ka kaulahao polypeptide beta e hoʻokumu i nā metabolites ikaika M1 (21A-Gly-insulin) a me M2 (21A-Gly-des-30B-Thr insulin). I loko o ka plasma, ʻo ka hana nui e hoʻolaha ka nui o ka metabolite M1. Hoʻonui ka hoʻonui ʻana o ka metabolite M1 e like me ke ʻano o Lantus i kuhikuhi ʻia.

Hōʻike nā hopena o ka lāʻau Pharmacokinetic a me ka lāʻau lapaʻau e pili ana i ka hopena o ke kōkōkohu subcutaneous o Lantus e pili pono ana i ka noho kaʻawale o ka M1 metabolite. ʻAʻole i ʻike ʻia ka insulin glargine a me ka metabolite M2 i ka hapa nui o nā mea maʻi, i ka manawa i loaʻa ai, kūʻokoʻa ko lākou ʻike ʻana i ka pualena i kuhikuhi ʻia o Lantus.

Ma nā hoʻokolohua lāʻau lapaʻau, ʻo ka nānā ʻana i nā subgroup i hoʻokumu ʻia e ka makahiki a me ka wahine e hōʻike i kahiʻokoʻa i ka hopena a me ka palekana ma waena o nā mea maʻi i mālama ʻia me ka glargine insulin a me ka huina o ka lehulehu i hoʻopaʻa ʻia.

Ua loiloi nā Pharmacokinetics i nā keiki i hala he 2 a me 6 mau makahiki me ka maʻi maʻi type 1 i loko o hoʻokahi noiʻi hauoli (ʻike ʻia "Pharmacodynamics"). ʻO ka “minima” pae kiʻekiʻe o ka insulin glargine a me kāna mau metabolites nui M1 a me M2 ua ana ʻia i loko o nā keiki i mālama ʻia me ka glargine insulin, a ua ʻike ʻia ua like nā kūlike o ka plasma e like me nā mea pākeke, nā hōʻike e kākoʻo ana i ka hōʻemi o ka glargine insulin a i ʻole nā ​​metabolites. me ka lōʻihi o ka lawelawe ʻana.

ʻO ka glargine Insulin he mea hoʻohālikelike o ka insulin kanaka, i hoʻolālā i ka haʻahaʻa haʻahaʻa ma ka pH kūleʻa. Hoʻopau piha loa i ka waikika pH o Lantus® Injection (pH 4). Ma hope o ka lawelawe ʻākala, ua neoneo ka hopena o ka waikawa, ka hoʻomōhala ʻana i ka microprecipitate, kahi mai ka hoʻomakeʻa ʻia ʻana o ka glargine insulin i loko o nā wahi liʻiliʻi, e hoʻolako ana i kahi kikoʻī, hoʻonaninani-ʻāpua, ʻike ʻia a me ka manawa lōʻihi me ka lōʻihi o ka hana.

Hoʻohālikelike i nā receptors insulin: i nā haʻawina vitro hōʻike i ka pilina o ka glargine insulin a me nā metabolites M1 a me M2 no nā mea hoʻonaninani insulin i ka like me ka insulin kanaka.

ʻO ka Hoʻonanea IGF-1 e kau nei: ka pilina o ka glargine insulin no ka mea hoʻokipa IGF-1 i loaʻa i ka manawa he 5-8 mau manawa ma mua o ka inika no ke kanaka (akā he 70-80 mau manawa haʻahaʻa ma mua o ka IGF-1), aʻo M1 metabolites a nakinaki ka M2 i ka mea i loaʻa i ka IGF-1 me kahi mea i hoʻohaʻahaʻa iki i hoʻohālikelike ʻia i ka insulin kanaka.

ʻO ka kuhi o ka therapeutic manaʻo o ka insulin (insulin glargine a me nā metabolites), i hoʻoholo ʻia i nā mea maʻi me ka type type diabetes mellitus, i mea hoʻohaʻahaʻa loa ʻia ma mua o ka makemake no ka hapalua nui o ka pane mai ka hopu ʻana o ka IGF-1 a me ka hana hou ʻana o ke ala proliferative mitogen i hoʻihoʻi ʻia e ka IGF-1 ka mea i loaʻa . ^ E Ha yM. Hiki i nā mea paʻa o ka phogenological o ka endogenous IGF-1 ke hiki i ka huakaʻi holomua proliferative ke ʻano, akā naʻe, ʻo ka ʻohi ʻana o ka therapeutic i hoʻoholo ʻia i ka wā o ka hoʻomāliʻi ʻana i ka insulin, a me ke ʻano ʻo Lantus, i hoʻohaʻahaʻa loa ʻia ma mua o nā kukuna pharmacological i koi ʻia e hoʻōla i ka ala IGF-1.

ʻO ka hana koʻikoʻi o ka insulin, me ka glargine insulin, ʻo ia ka hoʻoponopono ʻana i ka metabolism glucose. ʻO ka insulin a me nā panikini e hoʻokaʻawale i ke kiʻekiʻe o ka glucose koko ma ka hoʻonui ʻana i ka hoʻonui i ka glucose i loko o nā koina peripheral, ʻoi aku ka ʻiʻo skeletal a me ka iwi adipose, me ka ʻaina ʻana i ka hana glucose i loko o ka ate. Hoʻokomo ka Insulin i ka lipolysis ma adipocytes, keʻae i ka proteolysis a hoʻonui i ka synthesis protein. Ua hōʻike ʻia nā noiʻi ʻoihana ʻoihana ʻoiʻi a me ka lāʻau lapaʻau e like me ka hana like me ka insulin manuʻala a me nā insulin like ʻole i kūlike i ka wā i mālama ʻia i nā ʻano like like. E like me nā insulins a pau, hana kino a me nā mea ʻē aʻe i hiki ke hoʻoikaika i ka manawa o ka hana o ka glargine insulin.

E hoʻokuʻu i ke ʻano

Loaʻa ka Insulin i nā peni syringe. He ala kūpono kēia no ka maʻi maʻi, no ka mea hiki ke lawe ʻia i nā inikini ʻaʻole wale i ka hale, akā, i waho o ka home. He mea maʻalahi ke kū i ka pākaukau pololei me ka paʻa, no laila ʻaʻole loaʻa nā hihia nui loa. ʻO ka pahu pahu iā 5 mau pahu o 3 ml. Hoʻopili ʻia ka lāʻau lapaʻau i loko o kahi pahu pahu, aia kahi ʻōlelo aʻo no ka hoʻohana ʻana me ka wehewehe kikoʻī ʻana i ka hoʻohana ʻana i kēia huahana. ʻO ka mea hana o ka lāʻau lapaʻau ʻo Frankfurt am Main Germany, ʻo ka hana ʻana o Lūkini i ka lāʻau lapaʻau ʻo ZAO Sanofi-Aventis Vostok, Oryol Oblast.

Pharmacodynamics a me ka pharmacokinetics

Hoʻohālikelike ʻia ka lāʻau i ia ala me he haʻahaʻa haʻahaʻa ʻo ia i loko o kahi wai kūʻai kūwaho. I ka hoʻonā wai wai e hoʻomaʻamaʻa maikaʻi ʻia a paʻa loa. Ma hope o kahi hōʻomaʻomaʻo subcutaneous, lilo ke ʻano o ka acidic i pane ʻole, a kau ka lāʻau lapaʻau i ke ʻano o ka microcrystals, e komo mālie i ke kahe koko. Hōʻike kēia i kāna hana lōʻihi. Hoʻonui ka garela Insulin i ka uptake glucose e nā io, ʻoi aku ka momona o ka ʻiwi a me nā momona momona, a hoʻēmi ʻia ka hana glucose e ka ate. No laila, ʻo ka emi o ke kahe koko e loaʻa ana. Inā mākou e hoʻohālikelike i ka hana a isophane a me ka hoʻokele, hoʻomalu ka lua o ka ʻoluʻolu, me ke ʻano ʻole. ʻO ka lohi ʻana i nā lāʻau i hiki ke hoʻohana iā ia i hoʻokahi manawa i ka lā.

E like me ke ana o ka hoʻopili ʻana i nā ʻenehana i loko o ka insulin, ua pili loa ka harling a me ka insulin o ke kanaka, no laila ke kūpaʻa maikaʻi nei nā inikua o nā lāʻau e nā mea maʻi a hāʻawi i ka hopena i makemake ʻia. ʻIke ʻia kahi paʻa o ka lāʻau i ka wā ma hope o 2-4 mau lā mai ke kaha mua me ka hoʻokele ʻo kēlā me kēia lā. Hoʻomaʻamaʻi nā mea maʻi i ka hoʻomaka ʻana o ka hopena therapeutic 60 mau minuke ma hope o ka hoʻonā ʻia ʻana, hiki ke hopena ka hopena therapeutic 24-29 hola. Ma ke komo ʻana i ke kino, ʻo Lantus, e like me nā insulins a pau, pio ka pala a hoʻopio ʻia i loko o ka urine a me ka bile.

Nui! E hoʻohana i ka peni ʻo ka syringe e like me ka mea hōʻike mai ka mea hana. Pono e hoʻokomo i ka insulin subcutaneously i loko o ka ʻōpū, ka wāwae ʻākau (ʻōpū), poʻohiwi.

Nā hōʻailona a me nā contraindications

Hoʻokomo ka Insulin i ka hana o ka hōʻemi glucose, a me kona hemahema e hōʻuluʻulu i ka hōʻemi o ke kō i loko o ke koko, e hōʻoluʻolu iā ʻoe. Hoʻohana ʻia ʻo Solostar e mālama i kahi ʻano like ʻole o ka maʻi maʻi i kahi i loaʻa ai ka pilikia o ka hormone. Puhi kēia ʻano no ka lawa ʻole o ka pancreas ma muli o ka congenital a i loaʻa paha nā kumu. He kūlike ʻo Solotar me nā lāʻau lapaʻau e pili ana i ka insulin. I kēia hihia, pono ia e helu i kahi ʻokoʻa ʻē aʻe, koho iā ia i ka manaʻo i ka ʻokoʻa ʻana o ka manawa o ka hana. Hoʻohana ʻia ka lāʻau hoʻohui e mālama i nā maʻi maʻi 2 like ʻole.

ʻO ka hoʻohālikelike ʻana me ka hoʻohana ʻana iā Harling:

• allergy i kēlā me kēia mea o ka lāʻau a me nā mea ikaika,
• pilikia hōʻeha loa,
• keiki malalo o 2 mau makahiki.

ʻO kahi contraindication pili. Pono nā wahine hāpai i ka inikini ma lalo o ka kaohi mau o ka pae koko koko. Ke hoʻohālikelike nei, ʻoi aku ka nui o nā hoʻoponopono o ka hoʻokahi dosis, no laila, pono ke mālama ʻia ka lāʻau lapaʻau e kekahi kauka.

Nā hopena hopena

Kuhi ʻia i ka hana i ʻōlelo ʻia ai, ʻaʻole e hiki ke neʻe aku ka hopena me ke kino. Akā ʻo ka hoʻohana mau loa ʻana i ka insulin e hiki ke "hopena".I ka manawa pinepine, ʻo ia ka emi ʻana o ke kō o ke kō, e hōʻike ana iā ia iho:

• nāwaliwali
• nā mea kūlike ʻole
• ka mea kuʻe i ka ʻoihana sentral,
• mai nāwaliwali
• ka ʻaʻe ʻana o nā wāwae,
• huehue,
• he puʻuwai ikaika.

Me kahi hāʻule o ka glucose i lalo o ka pae, hiki i kahi comog hypoglycemic e ulu, kahi kūlana koʻikoʻi e koi ana i ka mālama olakino. I nā hana āpau, loaʻa i nā maʻi lolo nā wahi necrotic ma nā pūnaewele o nā inikina pinepine, no laila e hoʻololi ʻia kahi ʻoi. Inā ʻaʻole i ukali ʻia ka hoʻomaʻemaʻe, e lilo a ʻike ʻia ka maʻi injection, e hoʻonā ai i ka suppuration, ʻeha a me ka flush. ʻO nā mea maʻi e maʻi kūlohelohe a i ʻole he mōʻaukala o ka angioedema shock i hoʻāʻo ʻia no ka hoʻomanawanui ʻana o ka insulin. Ke hana nei i kēia, e hana i kahi kaukā kikākole me ke nānā i ke ʻano o ke kino. Inā ʻaʻohe mau hōʻike pilikino, hoʻomau ka lāʻau o ka insulin.

ʻO ka dosis a me ka wīwī

Hōʻike ʻia ʻo Lantus no ka mālama ʻana i ka maʻi diabetes i nā pākeke, nā ʻōpio a me nā keiki mai 2 mau makahiki o kona makahiki. Inā makemake ʻia ka insulin i kahi keiki ma lalo o ʻelua makahiki o hope iho, a laila e hoʻoholo paʻa ʻia ka pona kū hoʻokahi a ua helu ʻia ia ma muli o ke kaumaha o ke pēpē. ʻO ka mea hana o ka lāʻau lapaʻau i nā ʻōkuhi e hōʻike maopopo ana pehea a me kahi e lawelawe ai i ka lāʻau lapaʻau. Hoʻokomo ʻia ka insulin i loko o nā pākeke a me nā keiki subcutaniously hoʻokahi i ka lā, ʻaʻohe o ka manawa o ka lā, akā i ka manawa like. Pono ke ʻano o ka nui o ka lāʻau.

Me ka type 2 diabetes mellitus, hanaʻo Solostar e like me ka lāʻau hoʻokahi, a me ka ʻāpana o ka hui lāʻau. Pono ʻoe e hoʻoponopono i kēiaʻano o ka lāʻau lapaʻau ke kaʻaloli mai kahi ʻano o ka insulin i kekahi, me ka hoʻonui ʻana i ke kaumaha o ke kino, ke hoʻololi nei i ka papa o nā inikini. Hoʻopilikia kēia mau mea i ka hopena o ka lāʻau, no laila, koi i nā helu hou. Ma mua o ka hoʻohana ʻana i kahi peni syringe, wehewehe ke kauka i ka mea maʻi i ka ʻōlelo ʻana e hoʻopili ai, e hoʻokomo i ka pūpū, a koho i kahi wahi kūpono no ka maʻi maʻi. ʻAʻole pono ka lawaiʻa i nā loea kūikawā, no ka mea, he huila ʻili ʻo ka syringe a hana ʻia ka injection me ka ʻole o ka hoʻoikaika ʻana. Aia hoʻokahi ana i loko o ke kaʻina hana - pono i kahi maʻi maʻa ke aʻo kūʻokoʻa i ke ana ma ke ana ka nui o ka pona e pono ai no ka hoʻokele.

Nui! E hoʻokaʻawale i nā maʻi ma ke kahua o ka injection, hoʻohana hoʻokahi lāʻau i ka manawa hoʻokahi. Ma hope o ka ʻōlelo mua, mālama ʻia ka peni i kahi wahi pōʻeleʻele i ke keʻena lumi a hoʻohana ʻole i ʻoi aku ma mua o 1 mahina.

Inā ʻokiʻane a ʻeha paha ke ahonui i ka emi ʻana o ka hiki ke kānana i nā kaha, a i ka wā e hoʻololi ai mai ka ʻōmole a maʻalahi hoʻi i ka insulin i Solestar, ʻokoʻa ʻia ka liʻiliʻi o ka garglin. Hoʻokahi wale ke kauka hiki i kēia helu. I ka manawa pinepine, ua ʻōlelo ʻia ʻo "Lantus" i ka nui o 40-60% o ka ʻimi hoʻokaʻina i lawe ʻia ma mua. Hoʻolaha ʻia ka lāʻau lapaʻau liʻiliʻi no nā mea maʻi e lawe i nā lāʻau lapa me kahi hopena hypoglycemic.

ʻO ke kau palena o ka lāʻau ka hopena ma muli o:

• kuhi hewa ʻana i kahi nui i piʻi,
• hewa ke ana hewa,
• loli i ka pae injection,
• ka hoʻohana ʻana o kekahi mea ʻē aʻe o ka insulin.

I kēia hihia, kūkulu ka mea maʻi i ka hypoglycemia me ke kiʻi lāʻau e pili ana. ʻO ka hōʻeha ke mālama, hōʻailona ma ke ʻano.

Hoʻohui

Me ka hoʻokūkū pinepine ʻana o Lantus a me nā lāʻau lapaʻau mai nā hui lapaʻau ʻē aʻe, ua nānā ʻia kahi loli i ka lōʻihi o ka hana a ka insulin. Hiki i kekahi mau lāʻau lapaʻau ke hoʻoikaika i ka hana o ka insulin, ʻoiai ʻo kekahi e hōʻemi i ka hopena therapeutic. Hoʻonui ʻia ka hoʻonui ʻana i ka hopena hypoglycemic me ka hoʻopili ʻana o ka harling me:

• ʻO ACE inhibitors, MAO,
• Hoʻomākaukau huina salicylic
• huahi ʻailima
• nā lāʻau maʻi hypoglycemic waha.

Hoʻopilikia ʻia ka hana insulin e nā:

• waiʻona
• lawe i nā lāʻau lapaʻau e pili ana i ka hormone tiro.
• hoʻoiho
• lāʻau lapaʻau lāʻau
• nā lāʻau lapaʻau psychotropic.

I ke koho ʻana i ka harling insulin, pono ʻoe e ʻike i nā lāʻau ʻē aʻe e lawe ana i ka mea maʻi e hoʻoponopono pololei i ka ʻawaʻawa.

ʻO nā ʻatikala a i ʻole nā ​​mea like no Lantus Solostar he hopena like, akā naʻe ka ʻokoʻa i kahi hoʻonohonoho o nā mea kōkua.

Hāʻawi ka papa i ka papa inoa o nā meaʻala o ka lāʻau lapaʻau.

ʻO Tujeo Solostar kahi mea hou no Lantus. ʻAʻole i loaʻa ka "hopena ʻaoʻao", a hiki i ka hopena therapeutic i makemake ʻia, ʻoi ʻia he 3 manawa liʻiliʻi e koi ʻia ma mua o Lantus. Hoʻokuʻu ʻia ka lāʻau lapaʻau i loko o kahi peni syringe. Aia ma ka mea kumu, aia kahi palapala 300ED ma kahi papa meli-gula. Kiʻi:

ʻO nā mea kikoʻī e kūpono i ka mea maʻi, ke hoʻoholo nei ke kauka, i ka noʻonoʻo ʻana i ke papa lāʻau o ka maʻi a me ke ʻano o ka mea maʻi.

ʻO nā mea maʻi, a me nā kauka hoʻi, waiho i kā lākou ʻōlelo i ka Pūnaewele e pili ana i kēia lāʻau.

Angelina, 37 makahiki, endocrinologist. ʻO ia ʻo Lantus a me Tugiero ka like pū me ka mea like, akā i ka mākaukau ua ʻike hou aʻe lākou. Ke koi nui nei ka Tujeo ma waena o nā maʻi maʻi, no ka mea, pono ke hoʻemi haʻahaʻa ʻana i ke kō.

Ana, 32 makahiki. Hoʻohana ʻia ʻo Lantus, a laila huli ʻia ma Tujeo. Makemake wau iā ia ʻoi aku, ʻaʻohe "ʻaoʻao ʻaoʻao", ke kō ka maʻamau o ke kō.

Vladislav, 46 makahiki. Ua hala wau i ka maʻi maʻi i nā makahiki he 10. ʻO ka mea mua, ua hopu aku ʻo ia iā Basis Insulin, a laila ʻo Lantus. Ano ua hoʻololi ʻia iā Tujeo. Maikaʻi kaʻu maikaʻi, ʻaʻohe ʻano ʻino, akā, ʻaʻole poina ia e pili ana i ka meaʻai.

ʻO ke kumukūʻai o "Lantus" i nā lāʻau lapaʻau ma Lūkini e like paha me 2900 a 3200 mau rubles i pākuhi.